These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24722171)

  • 21. Late-onset hypogonadism: Reductio ad absurdum of the cardiovascular risk-benefit of testosterone replacement therapy.
    Sesti F; Pofi R; Minnetti M; Tenuta M; Gianfrilli D; Isidori AM
    Andrology; 2020 Nov; 8(6):1614-1627. PubMed ID: 32737921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone therapy in hypogonadal patients and the associated risks of cardiovascular events.
    Kharaba ZJ; Buabeid MA; Ibrahim NA; Jirjees FJ; Obaidi HJA; Kaddaha A; Khajehkarimoddini L; Alfoteih Y
    Biomed Pharmacother; 2020 Sep; 129():110423. PubMed ID: 32570122
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of testosterone replacement on whole body glucose utilisation and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism.
    Tripathy D; Shah P; Lakshmy R; Reddy KS
    Horm Metab Res; 1998 Oct; 30(10):642-5. PubMed ID: 9851674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular safety of testosterone replacement therapy in men: an updated systematic review and meta-analysis.
    Corona G; Rastrelli G; Sparano C; Carinci V; Casella G; Vignozzi L; Sforza A; Maggi M
    Expert Opin Drug Saf; 2024 May; 23(5):565-579. PubMed ID: 38553429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testosterone therapy in women with androgen deficiency: Its time has come.
    Guay A; Traish A
    Curr Opin Investig Drugs; 2010 Oct; 11(10):1116-26. PubMed ID: 20872314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of physical activity, sedentary behaviours and sleep duration with cardiovascular diseases and lipid profiles: a Mendelian randomization analysis.
    Zhuang Z; Gao M; Yang R; Li N; Liu Z; Cao W; Huang T
    Lipids Health Dis; 2020 May; 19(1):86. PubMed ID: 32384904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternatives to Testosterone Therapy: A Review.
    Lo EM; Rodriguez KM; Pastuszak AW; Khera M
    Sex Med Rev; 2018 Jan; 6(1):106-113. PubMed ID: 29174957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beneficial and adverse effects of testosterone on the cardiovascular system in men.
    Ruige JB; Ouwens DM; Kaufman JM
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4300-10. PubMed ID: 24064693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Trials of testosterone replacement reporting cardiovascular adverse events.
    Gagliano-Jucá T; Basaria S
    Asian J Androl; 2018; 20(2):131-137. PubMed ID: 28782738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials.
    Xu L; Freeman G; Cowling BJ; Schooling CM
    BMC Med; 2013 Apr; 11():108. PubMed ID: 23597181
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meta-analysis: statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular risk.
    Jafri H; Alsheikh-Ali AA; Karas RH
    Ann Intern Med; 2010 Dec; 153(12):800-8. PubMed ID: 21173414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. State-of-the-Art: a Review of Cardiovascular Effects of Testosterone Replacement Therapy in Adult Males.
    Elsherbiny A; Tricomi M; Bhatt D; Dandapantula HK
    Curr Cardiol Rep; 2017 Apr; 19(4):35. PubMed ID: 28361372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiometabolic Effects of Testosterone in Transmen and Estrogen Plus Cyproterone Acetate in Transwomen.
    van Velzen DM; Paldino A; Klaver M; Nota NM; Defreyne J; Hovingh GK; Thijs A; Simsek S; T'Sjoen G; den Heijer M
    J Clin Endocrinol Metab; 2019 Jun; 104(6):1937-1947. PubMed ID: 30602016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controversy over Cardiovascular Risks of Testosterone Therapy.
    Carter D
    Am J Nurs; 2015 May; 115(5):17. PubMed ID: 25906216
    [No Abstract]   [Full Text] [Related]  

  • 35. Testosterone Therapy and Cardiovascular Risk: A Critical Analysis of Studies Reporting Increased Risk.
    Khera M; Miner M; Jaffe J; Pastuszak AW
    J Sex Med; 2021 Jan; 18(1):83-98. PubMed ID: 33317996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Testosterone Replacement With Cardiovascular Outcomes Among Men With Androgen Deficiency.
    Cheetham TC; An J; Jacobsen SJ; Niu F; Sidney S; Quesenberry CP; VanDenEeden SK
    JAMA Intern Med; 2017 Apr; 177(4):491-499. PubMed ID: 28241244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testosterone therapy: has overuse undermined use?
    The Lancet Diabetes Endocrinology
    Lancet Diabetes Endocrinol; 2018 Mar; 6(3):157. PubMed ID: 29475492
    [No Abstract]   [Full Text] [Related]  

  • 38. Testosterone treatment and cardiovascular events in prescription database studies.
    Shores MM
    Asian J Androl; 2018; 20(2):138-144. PubMed ID: 28816202
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testosterone concentrations and risk of cardiovascular events in androgen-deficient men with atherosclerotic cardiovascular disease.
    Boden WE; Miller MG; McBride R; Harvey C; Snabes MC; Schmidt J; McGovern ME; Fleg JL; Desvigne-Nickens P; Anderson T; Kashyap M; Probstfield JL
    Am Heart J; 2020 Jun; 224():65-76. PubMed ID: 32335402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testosterone and cardiovascular disease--the controversy and the facts.
    Morgentaler A; Feibus A; Baum N
    Postgrad Med; 2015 Mar; 127(2):159-65. PubMed ID: 25708023
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.